2021 annual financial data
Entrada Therapeutics 2021 Operating cash flow
Entrada Therapeutics 2021 operating cash flow with verified reported values.
Direct answer
Operating cash flow was -50,862,000 USD.
Operating income was -51,127,000 USD and net income was -50,072,000 USD.
Operating cash flow was -50,862,000 USD.
Get free Entrada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -51,127,000 USD
- Net income
- -50,072,000 USD
- Operating cash flow
- -50,862,000 USD